{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:48:31Z","timestamp":1789573711358,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ijid.2021.09.050","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T12:11:48Z","timestamp":1632485508000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Prophylactic effect of cutaneous leishmaniasis against COVID-19: a case-control field assessment"],"prefix":"10.1016","volume":"122","author":[{"given":"Mehdi","family":"Bamorovat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Aflatoonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Karamoozian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Tahmouresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdollah","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amireh","family":"Heshmatkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Salarkia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabandeh","family":"Khaleghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nooshadokht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi Borhani","family":"Zarandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Barghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.09.050_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007423","article-title":"Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran","volume":"13","author":"Aflatoonian","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2021.09.050_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004349","article-title":"A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2021.09.050_bib0003","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2021.09.050_bib0004","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijid.2021.09.050_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007092","article-title":"Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates","volume":"13","author":"Bailey","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2021.09.050_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis\u2014Implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2021.09.050_bib0007","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.intimp.2019.02.008","article-title":"Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways","volume":"69","author":"Bamorovat","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijid.2021.09.050_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192236","article-title":"Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran","volume":"13","author":"Bamorovat","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2021.09.050_bib0009","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.micpath.2018.12.040","article-title":"A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models","volume":"128","author":"Bamorovat","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijid.2021.09.050_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.micpath.2018.01.021","article-title":"Leishmania tropica isolates from non-healed and healed patients in Iran: A molecular typing and phylogenetic analysis","volume":"116","author":"Bamorovat","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijid.2021.09.050_bib0011","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti\u2013IL-10 receptor antibody for sterile cure","volume":"194","author":"Belkaid","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijid.2021.09.050_bib0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S003118200001698X","article-title":"Concomitant infections, parasites and immune responses","volume":"122","author":"Cox","year":"2001","journal-title":"Parasitology-Cambridge"},{"key":"10.1016\/j.ijid.2021.09.050_bib0013","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.050_bib0014","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/bmj.326.7385.377","article-title":"Leishmaniasis: new approaches to disease control","volume":"326","author":"Davies","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.ijid.2021.09.050_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004545","article-title":"Old world cutaneous leishmaniasis and refugee crises in the Middle East and North Africa","volume":"10","author":"Du","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2021.09.050_bib0016","article-title":"Strategic framework for leishmaniasis control in the WHO European Region 2014\u20132020","author":"Ejov","year":"2014","journal-title":"Copenhagen World Heal Organ Reg Off Eur"},{"key":"10.1016\/j.ijid.2021.09.050_bib0017","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijid.2021.09.050_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00425","article-title":"Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection","volume":"10","author":"Frank","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijid.2021.09.050_bib0019","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1128\/iai.61.9.4008-4012.1993","article-title":"Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages","volume":"61","author":"Gessner","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijid.2021.09.050_bib0020","article-title":"Analysis of a summary network of co-infection in humans reveals that parasites interact most via shared resources","volume":"281","author":"Griffiths","year":"2014","journal-title":"Proc R Soc B Biol Sci"},{"key":"10.1016\/j.ijid.2021.09.050_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100817","article-title":"SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt","volume":"38","author":"Iesa","year":"2020","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.ijid.2021.09.050_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118102","article-title":"Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions","author":"Jafarzadeh","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.ijid.2021.09.050_bib0023","article-title":"Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I-and III Interferons","author":"Jafarzadeh","year":"2020","journal-title":"Viral Immunol"},{"key":"10.1016\/j.ijid.2021.09.050_bib0024","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/iub.2129","article-title":"Leishmania species-dependent functional duality of toll-like receptor 2","volume":"71","author":"Jafarzadeh","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijid.2021.09.050_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.vaccine.2007.10.044","article-title":"Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates","volume":"26","author":"Jafarzadeh","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.09.050_bib0026","doi-asserted-by":"crossref","first-page":"280","DOI":"10.26719\/2015.21.4.280","article-title":"Effectiveness of meglumine antimoniate against L. tropica in a recently emerged focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran","volume":"21","author":"Karamian","year":"2015","journal-title":"EMHJ-Eastern Mediterr Heal J"},{"key":"10.1016\/j.ijid.2021.09.050_bib0027","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.09.050_bib0028","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"key":"10.1016\/j.ijid.2021.09.050_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.ijid.2021.09.050_bib0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.imbio.2007.12.005","article-title":"The innate immune response against Leishmania parasites","volume":"213","author":"Liese","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijid.2021.09.050_bib0031","first-page":"1","article-title":"Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review","author":"Lingeswaran","year":"2020","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.ijid.2021.09.050_bib0032","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1080\/21645515.2020.1818522","article-title":"BCG vaccine: a hope to control COVID-19 pandemic amid crisis","volume":"16","author":"Malik","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2021.09.050_bib0033","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.4049\/jimmunol.164.3.1458","article-title":"IL-13 is a susceptibility factor for Leishmania major infection","volume":"164","author":"Matthews","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2021.09.050_bib0034","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/vim.2017.0018","article-title":"Helper T cell responses to respiratory viruses in the lung: development, virus suppression, and pathogenesis","volume":"30","author":"Miyauchi","year":"2017","journal-title":"Viral Immunol"},{"key":"10.1016\/j.ijid.2021.09.050_bib0035","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1017\/S0031182000072243","article-title":"Experiences with vaccines against cutaneous leishmaniasis: of men and mice","volume":"98","author":"Modabber","year":"1989","journal-title":"Parasitology"},{"key":"10.1016\/j.ijid.2021.09.050_bib0036","article-title":"BCG vaccination induced protection from COVID-19","author":"Mohapatra","year":"2020","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.ijid.2021.09.050_bib0037","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2021.09.050_bib0038","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"76","author":"Nadim","year":"1983","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"10.1016\/j.ijid.2021.09.050_bib0039","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4049\/jimmunol.0901114","article-title":"Regulatory B cells shape the development of Th2 immune responses in BALB\/c mice infected with Leishmania major through IL-10 production","volume":"184","author":"Ronet","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2021.09.050_bib0040","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3389\/fimmu.2020.01573","article-title":"Interleukin-27 Functional Duality Balances Leishmania Infectivity and Pathogenesis","volume":"11","author":"Saha","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2021.09.050_bib0041","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijid.2021.09.050_bib0042","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.050_bib0043","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clinthera.2013.01.007","article-title":"Nonspecific effects of vaccines and the reduction of mortality in children","volume":"35","author":"Shann","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijid.2021.09.050_bib0044","first-page":"299","article-title":"A comprehensive review of cutaneous leishmaniasis in Kerman Province, Southeastern Iran-narrative review article","volume":"44","author":"Sharifi","year":"2015","journal-title":"Iran J"},{"key":"10.1016\/j.ijid.2021.09.050_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40249-019-0560-6","article-title":"Infection against infection: parasite antagonism against parasites, viruses and bacteria","volume":"8","author":"Shen","year":"2019","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.ijid.2021.09.050_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2020.06.064","article-title":"Do parasite infections interfere with immunisation? A review and meta-analysis","author":"Wait","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.09.050_bib0047","unstructured":"World Health Organization. Global Health Observatory data repository: Number of cases of cutaneous leishmaniasis reported. 2017."},{"key":"10.1016\/j.ijid.2021.09.050_bib0048","series-title":"Responding to community spread of COVID-19: interim guidance, 7 March 2020","year":"2020"},{"key":"10.1016\/j.ijid.2021.09.050_bib0049","series-title":"Bacille Calmette-Gu\u00e9rin (BCG) vaccination and COVID-19: scientific brief, 12 April 2020","year":"2020"},{"key":"10.1016\/j.ijid.2021.09.050_bib0050","unstructured":"World Health Organization. Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region 2014."},{"key":"10.1016\/j.ijid.2021.09.050_bib0051","first-page":"1","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","author":"Zou","year":"2020","journal-title":"Front Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T00:57:55Z","timestamp":1692493075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221007578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":51,"alternative-id":["S1201971221007578"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.050","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic effect of cutaneous leishmaniasis against COVID-19: a case-control field assessment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}